Search research articles
Contact Us
Filters
Showing results (91-100 of 169) with videos related to
Page
of 17
Sort By:
The Lancet. Oncology
|
March 30, 2012
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin, Marc S Ernstoff, Omid Hamid, et al.
Academic Radiology
|
January 21, 2014
Clinical EPR: unique opportunities and some challenges
Harold M Swartz, Benjamin B Williams, Bassem I Zaki, et al.
Plos One
|
November 3, 2012
Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy
Adrian Schwarzer, Benita Wolf, Jan L Fisher, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Joseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
JCO Precision Oncology
|
March 17, 2023
Pathway Alterations in Stage II/III Primary Melanoma
Caroline E Kostrzewa, Li Luo, Arshi Arora, et al.
Melanoma Research
|
March 15, 2016
The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells
Chery A Whipple, Andrea Boni, Jan L Fisher, et al.
Nature Cancer
|
June 28, 2021
Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy
Jichang Han, Yanding Zhao, Keisuke Shirai, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal Samples
Arshi Arora, Li Luo, Caroline E Kostrzewa, et al.
Cancer Immunology, Immunotherapy : CII
|
December 13, 2016
Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma
Alissa A Thomas, Jan L Fisher, Thomas H Hampton, et al.
The Journal of Urology
|
February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma
Thomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 169) with videos related to
Sort By:
Page
of 17
The Lancet. Oncology
|
March 30, 2012
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin, Marc S Ernstoff, Omid Hamid, et al.
Academic Radiology
|
January 21, 2014
Clinical EPR: unique opportunities and some challenges
Harold M Swartz, Benjamin B Williams, Bassem I Zaki, et al.
Plos One
|
November 3, 2012
Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy
Adrian Schwarzer, Benita Wolf, Jan L Fisher, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Joseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
JCO Precision Oncology
|
March 17, 2023
Pathway Alterations in Stage II/III Primary Melanoma
Caroline E Kostrzewa, Li Luo, Arshi Arora, et al.
Melanoma Research
|
March 15, 2016
The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells
Chery A Whipple, Andrea Boni, Jan L Fisher, et al.
Nature Cancer
|
June 28, 2021
Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy
Jichang Han, Yanding Zhao, Keisuke Shirai, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal Samples
Arshi Arora, Li Luo, Caroline E Kostrzewa, et al.
Cancer Immunology, Immunotherapy : CII
|
December 13, 2016
Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma
Alissa A Thomas, Jan L Fisher, Thomas H Hampton, et al.
The Journal of Urology
|
February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma
Thomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
Page
of 17